Literature DB >> 4295776

Clearing-factor lipase in adipose tissue. Studies with puromycin and actinomycin.

D R Wing, D S Robinson.   

Abstract

1. When adipose tissue from starved rats is incubated in a medium containing glucose, insulin, heparin and actinomycin (5mug./ml.) the total clearing-factor lipase activity of the system increases at least tenfold over a period of 9hr. In the absence of actinomycin, enzyme activity also increases, but to a lesser extent and for only about 3hr. Some enzyme activity appears in the incubation medium in both the presence and the absence of actinomycin. 2. When the glucose and insulin of the incubation medium are replaced by pyruvate and heparin is omitted, an increase in the total clearing-factor lipase activity in the presence of actinomycin still occurs, but only after a lag of several hours. When only heparin is omitted from the medium, the rise in enzyme activity begins immediately, but there is a shoulder in the time-course curve after a few hours. In the absence of heparin, little enzyme activity appears in the incubation medium. 3. The increases in enzyme activity in the presence of actinomycin are prevented if puromycin (0.5mg./ml.) is present in the incubation medium. 4. Catecholamines and corticotrophin inhibit the increase in enzyme activity caused by actinomycin. 5. The clearing-factor lipase activity of adipose tissue from fed animals declines with a half-life of between 1 and 1.5hr. when the tissue is incubated in the presence of puromycin. The clearing-factor lipase activity of adipose tissue from starved animals is stable under similar circumstances, as is the raised activity found after such tissue has been incubated in the presence of actinomycin. 6. Clearing-factor lipase extracted from adipose tissue of fed animals is less stable in solution than that extracted from the tissue of starved animals after this has been incubated in the presence of actinomycin.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4295776      PMCID: PMC1198557          DOI: 10.1042/bj1060667

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  ACTIVATION OF AN EPINEPHRINE-SENSITIVE LIPOLYTIC ACTIVITY FROM ADIPOSE TISSUE BY ADENOSINE 3',5'-PHOSPHATE.

Authors:  M A RIZACK
Journal:  J Biol Chem       Date:  1964-02       Impact factor: 5.157

Review 2.  THE ADIPOKINETIC ACTION OF POLYPEPTIDE AND AMINE HORMONES UPON THE ADIPOSE TISSUE OF VARIOUS ANIMAL SPECIES.

Authors:  D RUDMAN
Journal:  J Lipid Res       Date:  1963-04       Impact factor: 5.922

3.  A PARADOXICAL EFFECT OF ACTINOMYCIN D: THE MECHANISM OF REGULATION OF ENZYME SYNTHESIS BY HYDROCORTISONE.

Authors:  L D GARREN; R R HOWELL; G M TOMKINS; R M CROCCO
Journal:  Proc Natl Acad Sci U S A       Date:  1964-10       Impact factor: 11.205

Review 4.  THE CLEARING FACTOR LIPASE AND ITS ACTION IN THE TRANSPORT OF FATTY ACIDS BETWEEN THE BLOOD AND TISSUES.

Authors:  D S ROBINSON
Journal:  Adv Lipid Res       Date:  1963

Review 5.  THE ACTION OF EPINEPHRINE AND THE ROLE OF THE ADENYL CYCLASE SYSTEM IN HORMONE ACTION.

Authors:  E W SUTHERLAND; I OYE; R W BUTCHER
Journal:  Recent Prog Horm Res       Date:  1965

6.  FAILURE OF ACTINOMYCIN D TO PREVENT INDUCTION OF LIVER APOFERRITIN AFTER IRON ADMINISTRATION.

Authors:  J W DRYSDALE; H N MUNRO
Journal:  Biochim Biophys Acta       Date:  1965-05-11

7.  Significance of adipose tissue lipoprotein lipase.

Authors:  J PAV; J WENKEOVA
Journal:  Nature       Date:  1960-03-26       Impact factor: 49.962

8.  Tissue distribution of C14 after the intravenous injection of labeled chylomicrons and unesterified fatty acids in the rat.

Authors:  J H BRAGDON; R S GORDON
Journal:  J Clin Invest       Date:  1958-04       Impact factor: 14.808

9.  Puromycin: a potent metabolic effect independent of protein synthesis.

Authors:  M M Appleman; R G Kemp
Journal:  Biochem Biophys Res Commun       Date:  1966-08-23       Impact factor: 3.575

10.  INDUCTION OF SEVERAL ADAPTIVE ENZYMES BY ACTINOMYCIN D.

Authors:  F ROSEN; P N RAINA; R J MILHOLLAND; C A NICHOL
Journal:  Science       Date:  1964-10-30       Impact factor: 47.728

View more
  19 in total

1.  Clearing-factor lipase in adipose tissue. Distinction of different states of the enzyme and the possible role of the fat cell in the maintenance of tissue activity.

Authors:  V J Cunningham; D S Robinson
Journal:  Biochem J       Date:  1969-04       Impact factor: 3.857

2.  Clearing-factor lipase in adipose tissue. A possible role of adenosine 3',5'-(cyclic)-monophosphate in the regulation of its activity.

Authors:  D R Wing; D S Robinson
Journal:  Biochem J       Date:  1968-10       Impact factor: 3.857

3.  The effect of cycloheximide on adipose-tissue clearing-factor lipase.

Authors:  A Cryer; B Foster; D R Wing; D S Robinson
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

Review 4.  [Regulation of cholesterol synthesis].

Authors:  B Hamprecht
Journal:  Naturwissenschaften       Date:  1969-08

5.  Stability of clearing-factor lipase in rat adipose tissue.

Authors:  P Davies; D S Robinson
Journal:  Biochem J       Date:  1973-10       Impact factor: 3.857

6.  Stabilization and partial purification of lipoprotein lipase.

Authors:  D Reichl
Journal:  Biochem J       Date:  1969-10       Impact factor: 3.857

7.  Adipose-tissue lipoprotein lipase activity in rats adapted to controlled feeding schedules.

Authors:  D Reichl
Journal:  Biochem J       Date:  1970-10       Impact factor: 3.857

8.  The effects of streptozotocin diabetes on tissue specific lipase activities in the rat.

Authors:  T Nomura; Y Hagino; M Gotoh; A Iguchi; N Sakamoto
Journal:  Lipids       Date:  1984-08       Impact factor: 1.880

9.  Stimulation of liver cholesterol synthesis by actinomycin D.

Authors:  F De Matteis
Journal:  Biochem J       Date:  1968-10       Impact factor: 3.857

10.  The significance of changes in tissue clearing-factor lipase activity in relation to the lipaemia of pregnancy.

Authors:  S Otway; D S Robinson
Journal:  Biochem J       Date:  1968-02       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.